Keytruda (pembrolizumab) is a cancer medicine that interferes with the growth and spread of cancer cells in the body. If you have question, please e-mail Allevaire Indian Team or call Allevaire India on +91-9818274099 (Mr. Kamal Kaushal) for further details.
Keytruda (pembrolizumab) is a cancer medicine that interferes with the growth and spread of cancer cells in the body.KEYTRUDA is indicated for the adjuvant treatment of patients with melanoma with involvement of lymph node.
Keytruda is used alone or in combination with other medicines to treat certain types of cancer
Keytruda (Pembrolizumab) Injection suppliers in India. Allevaire India New Delhi, INDIA.
Alleviare Life sciences Pvt. Ltd. is a consulting pharmaceutical company specialized in providing medicines under Named Patient Program/Manage Access Program. Named Patient Program/ Manage Access Program is a program designed by the government of India and governments of many countries worldwide for patients who have exhausted the treatment options available in their respective countries and are in need of latest medicines that are available in countries of Europe and USA.
Alleviare Life Sciences connects the buyer with the supplier who can ship Keytruda (Pembrolizumab) (Cancer Treatment Medicines) to any country of the world as per the buyer’s requirement and Government regulations of the country. Keytruda (Pembrolizumab) is manufactured by Merck & Co. Inc.
Alleviare Life Sciences provides options for choosing exporter and supplier of Cancer treatment Medicines We take guarantee of quality and delivery anywhere in the world as per the buyer’s requirements.
The order for Keytruda (Pembrolizumab) Injection will be confirmed only after the receipt of valid prescription of doctor and import permit if applicable.
KEYTRUDA® (pembrolizumab) is indicated for the treatment of patients with unresectable or metastatic melanoma and disease progression following ipilimumab and, if BRAF V600 mutation positive, a BRAF inhibitor.
Limitation of Use:
Keytruda is given as an infusion into a vein, usually once every 3 weeks. A healthcare provider will give you this injection.
Medicine Name: Keytruda
Generic Name: Pembrolizumab
Approval Date: September 4, 2019.
Company Name: Merck & Co., Inc.
Please contact +91 9818274099 for Keytruda (Pembrolizumab) price in India
We take guarantee of quality and delivery anywhere in the world as per the buyer’s requirements.
The most common side effects of KEYTRUDA include: feeling tired, cough, nausea, itching, rash, decreased appetite, constipation, joint pain, diarrhea.
FDA approves Keytruda for advanced melanoma.
Administer 2 mg/kg as an intravenous infusion over 30 minutes every 3 weeks
Dilute prior to intravenous infusion
Keytruda is available.
Get In Touch
ALS helps patients, doctors and hospitals as a facilitator to import prescription medicine brand Keytruda (Pembrolizumab) Injection on prescription and Import License in Patient’s Name only.
For foreign countries patients, Keytruda (Pembrolizumab) Injection can be made available in Send your inquiry to find Keytruda (Pembrolizumab) Injection in China, Cambodia, Indonesia the Philippines, Singapore, Thailand, Vietnam, Hong Kong. UAE Iraq, Iran, Saudi Arabia, Jordan, Mexico, Argentina, Brazil, Chile, Colombia, Peru, Venezuela. Europe – Romania, Switzerland, Georgia, Turkey, Italy, UK, Ukraine, Azerbaijan, Latvia, Poland, Slovakia. Russia CIS – Armenia, Kazakhstan, Moldova, Tajikistan, Turkmenistan, Uzbekistan, Mongolia, Algeria, Mauritius, Uganda, Zimbabwe. Australia and New Zealand.
For Keytruda (Pembrolizumab) Injection Indications And Usage, Dosage And Administration, Dosage Forms And Strengths and Drug Interactions For More Details